Invivoscribe is dedicated to improving the quality of healthcare worldwide by providing high quality, reliable, cutting-edge tools for molecular biology, molecular diagnostics, and Personalized Molecular Medicine?. Products manufactured in our GMP facility include a comprehensive selection of PCR-based reagents and controls for gene rearrangement, chromosome translocation, and gene mutation testing. Customers include pharmaceutical and biotechnology companies; cancer research, academic and hospital testing centers, and reference laboratories. Our CE-marked IVD products, which are available for sale and use outside North America, target biomarkers that have demonstrated clinical utility. Our tests are used to identify, stratify and monitor hematologic cancers. Our companion diagnostic products assist in the development of pharmaceutical agents and devices. Many of our gene rearrangement and gene mutation testing products are covered by exclusive-licensed patents. Mission:?Our goal is to provide patients access to the right medications, in the right amount, at the right time, for the right disease.
51 to 200 Employees
TypeCompany - Private
Revenue$10 to $25 million (USD)
IndustryBiotech & Pharmaceuticals
CompetitorsUnknown
Founded1995